Big drug companies step up long-term care promotion.NEWTOWN Newtown, town (1990 pop. 20,779), Fairfield co., SW Conn., on the Housatonic; inc. 1711. Pressure gauges, plastics, and paper and metal products are made, and dairy and fruit farms are in the area. , Pa.--(BW HealthWire)--Feb. 3, 1997-- The pharmaceutical companies most actively promoting to long-term care long-term care (LTC), n the provision of medical, social, and personal care services on a recurring or continuing basis to persons with chronic physical or mental disorders. include: -0-
Eli Lilly
Bristol-Myers Squibb
Merck
Glaxo Wellcome
Hoechst Marion Roussel
SOURCE: Scott-Levin, Fall 1996 Nursing Home Pharmacy
Provider/Consultant Promotional Audit
Some of the largest pharmaceutical companies are working harder to capture a share of the long-term care (LTC LTC abbr. lieutenant colonel ) market as these lives are being transferred into managed care. The five most active companies during the eight-week data-collection period for Scott-Levin's Fall 1996 Nursing Home Pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent. Provider/Consultant Promotional Audit were Lilly For lily, the flower, see . Lilly is a surname and a female given name, and may refer to: People
The Scott-Levin audit monitors promotional activities of pharmaceutical companies to pharmacists This is a list of notable pharmacists.
A closer look at some of the top companies: -0- -- Lilly's contacts to LTC increased 54% since spring 1996. The firm's promotional focus, which previously leaned toward Prozac, has changed. The majority of Lilly's contacts during fall 1996 involved representatives detailing the new antipsychotic Zyprexa, which accounted for 61% of Lilly's product mentions. -- Bristol-Myers Squibb increased LTC promotion by 53% since spring 1996. Promotional activity centered on Maxipime, BMS' new cephalosporin antibiotic, which accounted for 35% of the company's product mentions. Sales representatives' conversations with LTC pharmacists emphasized cost savings. -- Merck's LTC activity increased 21% from the spring audit cycle. Merck's promotional strategy switched from detailing the postmenopausal osteoporosis treatment Fosamax to offering numerous "value-added services" -- educational programs and other support -- for the product. -- Following HMR's steep decline in LTC promotion in the spring 1996 audit, the company boosted contacts by 92% during the fall data-collection period, raising HMR from 18th place to fifth. Contract-related contacts increased 180%, with pricing for Rugby's generic product line most frequently discussed. -- Outside the top five, Schein showed a renewed interest in the LTC market, placing among the top 20 companies in promotional activity during the fall 1996 audit. Most contacts involved contracting issues for the antibiotic cefaclor, the generic version of Ceclor. For more information on the audit, contact Kathy Carlson at 215/860-0440; fax: 215/860-5477 or e-mail: marketing@scottlevin.com. Scott-Levin offers the pharmaceutical industry a full complement of managed care services that monitor key areas such as product promotion, industry trends, retail pharmacy activity and market performance. The company, a division of PMSI/Scott-Levin, provides information used by more than 80 U.S. and international pharmaceutical clients. CONTACT: Managed Care Marketing Kathy Carlson, 215/860-0440 E-mail: marketing@scottlevin.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion